CIK 0000874716
- Large accelerated filer
IDEXX LABORATORIES INC /DE
Sign in to watch- Ticker
- IDXX
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 010393723
- Phone
- +1 207-556-0300
- Business address
- ONE IDEXX DRIVE, WESTBROOK, ME, 04092-2041
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $28,567,935
- in 5 filings
Net −$28,567,935. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- MAZELSKY JONATHAN JAY −$17.7M Executive Chair of the Board sold 23% of stake
- Underberg Sharon E. −$6.1M EVP, GC & Corporate Secretary sold 55% of stake
- Lane Michael −$2.7M Executive Vice President sold 49% of stake
- Kingsley Lawrence D −$1.2M Director sold 19% of stake
- JUNIUS DANIEL M −$845K Director sold 34% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-07 | MAZELSKY JONATHAN JAY President and CEO | Sale | −1,353 | $574.75 | $778K | 79,951.59 |
| 2024-02-07 | MAZELSKY JONATHAN JAY President and CEO | Sale | −705 | $575.48 | $406K | 79,246.59 |
| 2024-02-07 | MAZELSKY JONATHAN JAY President and CEO | Option exercise · Non-Qualified Stock Option (right-to-buy) | −12,000 | 29,260 | ||
| 2024-01-30 | JUNIUS DANIEL M Director | Grant or award | +14 | $521.03 | $7K | 3,042 |
| 2023-12-07 | POLEWACZYK JAMES F Executive Vice President | Option exercise | +4,956 | $206.94 | $1.0M | 15,005.99 |
| 2023-12-07 | POLEWACZYK JAMES F Executive Vice President | Option exercise | +6,680 | $288.78 | $1.9M | 21,685.99 |
| 2023-12-07 | POLEWACZYK JAMES F Executive Vice President | Sale | −3,116 | $520.19 | $1.6M | 18,569.99 |
| 2023-12-07 | POLEWACZYK JAMES F Executive Vice President | Sale | −3,378 | $521.00 | $1.8M | 15,191.99 |
| 2023-12-07 | POLEWACZYK JAMES F Executive Vice President | Sale | −1,202 | $522.31 | $628K | 13,989.99 |
| 2023-12-07 | POLEWACZYK JAMES F Executive Vice President | Sale | −3,940 | $523.56 | $2.1M | 10,049.99 |
| 2023-12-07 | POLEWACZYK JAMES F Executive Vice President | Option exercise · Non-Qualified Stock Option (right-to-buy) | −4,956 | 755 | ||
| 2023-12-07 | POLEWACZYK JAMES F Executive Vice President | Option exercise · Non-Qualified Stock Option (right-to-buy) | −6,680 | 2,226 | ||
| 2023-12-04 | MAZELSKY JONATHAN JAY President and CEO | Option exercise | +13,424 | $79.54 | $1.1M | 86,361.35 |
| 2023-12-04 | MAZELSKY JONATHAN JAY President and CEO | Sale | −5,804 | $512.95 | $3.0M | 80,557.35 |
| 2023-12-04 | MAZELSKY JONATHAN JAY President and CEO | Sale | −1,324 | $513.51 | $680K | 79,233.35 |
| 2023-12-04 | MAZELSKY JONATHAN JAY President and CEO | Option exercise · Non-Qualified Stock Option (right-to-buy) | −13,424 | 0 | ||
| 2023-12-04 | AYERS JONATHAN W Director | Gift | −2,424 | 272,594 | ||
| 2023-11-29 | AYERS JONATHAN W Director | Gift | −1,850 | 275,018 | ||
| 2023-11-20 | AYERS JONATHAN W Director | Gift | −2,506 | 276,868 | ||
| 2023-11-15 | AYERS JONATHAN W Director | Gift | −2,494 | 279,374 |
Page 38 of 52 · 1,036 trades